A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss
Macrothrombocytopenia (MTP) is a heterogeneous group of disorders characterized by enlarged and reduced numbers of circulating platelets, sometimes resulting in abnormal bleeding. In most MTP, this phenotype arises because of altered regulation of platelet formation from megakaryocytes (MKs). We report the identification of DIAPH1, which encodes the Rho-effector diaphanous-related formin 1 (DIAPH1), as a candidate gene for MTP using exome sequencing, ontological phenotyping, and similarity regression. We describe 2 unrelated pedigrees with MTP and sensorineural hearing loss that segregate with a DIAPH1 R1213* variant predicting partial truncation of the DIAPH1 diaphanous autoregulatory domain. The R1213* variant was linked to reduced proplatelet formation from cultured MKs, cell clustering, and abnormal cortical filamentous actin. Similarly, in platelets, there was increased filamentous actin and stable microtubules, indicating constitutive activation of DIAPH1. Overexpression of DIAPH1 R1213* in cells reproduced the cytoskeletal alterations found in platelets. Our description of a novel disorder of platelet formation and hearing loss extends the repertoire of DIAPH1-related disease and provides new insight into the autoregulation of DIAPH1 activity..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:127 |
|---|---|
| Enthalten in: |
Blood - 127(2016), 23, Seite 2903-2914 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stritt, Simon [VerfasserIn] |
|---|
| Links: |
|---|
| RVK: |
|---|
| doi: |
10.1182/blood-2015-10-675629 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC197822382X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC197822382X | ||
| 003 | DE-627 | ||
| 005 | 20230714200929.0 | ||
| 007 | tu | ||
| 008 | 160719s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2015-10-675629 |2 doi | |
| 028 | 5 | 2 | |a PQ20160719 |
| 035 | |a (DE-627)OLC197822382X | ||
| 035 | |a (DE-599)GBVOLC197822382X | ||
| 035 | |a (PRQ)c1041-ac53fb66feb78148a3ece9cbf5825b0838984659f2c0ccdf8328c8360e219eb00 | ||
| 035 | |a (KEY)0186192120160000127002302903gainoffunctionvariantindiaph1causesdominantmacroth | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 33000 |q AVZ |2 rvk | ||
| 100 | 1 | |a Stritt, Simon |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Macrothrombocytopenia (MTP) is a heterogeneous group of disorders characterized by enlarged and reduced numbers of circulating platelets, sometimes resulting in abnormal bleeding. In most MTP, this phenotype arises because of altered regulation of platelet formation from megakaryocytes (MKs). We report the identification of DIAPH1, which encodes the Rho-effector diaphanous-related formin 1 (DIAPH1), as a candidate gene for MTP using exome sequencing, ontological phenotyping, and similarity regression. We describe 2 unrelated pedigrees with MTP and sensorineural hearing loss that segregate with a DIAPH1 R1213* variant predicting partial truncation of the DIAPH1 diaphanous autoregulatory domain. The R1213* variant was linked to reduced proplatelet formation from cultured MKs, cell clustering, and abnormal cortical filamentous actin. Similarly, in platelets, there was increased filamentous actin and stable microtubules, indicating constitutive activation of DIAPH1. Overexpression of DIAPH1 R1213* in cells reproduced the cytoskeletal alterations found in platelets. Our description of a novel disorder of platelet formation and hearing loss extends the repertoire of DIAPH1-related disease and provides new insight into the autoregulation of DIAPH1 activity. | ||
| 540 | |a Nutzungsrecht: © 2016 by The American Society of Hematology. | ||
| 700 | 1 | |a Nurden, Paquita |4 oth | |
| 700 | 1 | |a Turro, Ernest |4 oth | |
| 700 | 1 | |a Greene, Daniel |4 oth | |
| 700 | 1 | |a Jansen, Sjoert B |4 oth | |
| 700 | 1 | |a Westbury, Sarah K |4 oth | |
| 700 | 1 | |a Petersen, Romina |4 oth | |
| 700 | 1 | |a Astle, William J |4 oth | |
| 700 | 1 | |a Marlin, Sandrine |4 oth | |
| 700 | 1 | |a Bariana, Tadbir K |4 oth | |
| 700 | 1 | |a Kostadima, Myrto |4 oth | |
| 700 | 1 | |a Lentaigne, Claire |4 oth | |
| 700 | 1 | |a Maiwald, Stephanie |4 oth | |
| 700 | 1 | |a Papadia, Sofia |4 oth | |
| 700 | 1 | |a Kelly, Anne M |4 oth | |
| 700 | 1 | |a Stephens, Jonathan C |4 oth | |
| 700 | 1 | |a Penkett, Christopher J |4 oth | |
| 700 | 1 | |a Ashford, Sofie |4 oth | |
| 700 | 1 | |a Tuna, Salih |4 oth | |
| 700 | 1 | |a Austin, Steve |4 oth | |
| 700 | 1 | |a Bakchoul, Tamam |4 oth | |
| 700 | 1 | |a Collins, Peter |4 oth | |
| 700 | 1 | |a Favier, Rémi |4 oth | |
| 700 | 1 | |a Lambert, Michele P |4 oth | |
| 700 | 1 | |a Mathias, Mary |4 oth | |
| 700 | 1 | |a Millar, Carolyn M |4 oth | |
| 700 | 1 | |a Mapeta, Rutendo |4 oth | |
| 700 | 1 | |a Perry, David J |4 oth | |
| 700 | 1 | |a Schulman, Sol |4 oth | |
| 700 | 1 | |a Simeoni, Ilenia |4 oth | |
| 700 | 1 | |a Thys, Chantal |4 oth | |
| 700 | 1 | |a Gomez, Keith |4 oth | |
| 700 | 1 | |a Erber, Wendy N |4 oth | |
| 700 | 1 | |a Stirrups, Kathleen |4 oth | |
| 700 | 1 | |a Rendon, Augusto |4 oth | |
| 700 | 1 | |a Bradley, John R |4 oth | |
| 700 | 1 | |a van Geet, Chris |4 oth | |
| 700 | 1 | |a Raymond, F Lucy |4 oth | |
| 700 | 1 | |a Laffan, Michael A |4 oth | |
| 700 | 1 | |a Nurden, Alan T |4 oth | |
| 700 | 1 | |a Nieswandt, Bernhard |4 oth | |
| 700 | 1 | |a Richardson, Sylvia |4 oth | |
| 700 | 1 | |a Freson, Kathleen |4 oth | |
| 700 | 1 | |a Ouwehand, Willem H |4 oth | |
| 700 | 1 | |a Mumford, Andrew D |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 127(2016), 23, Seite 2903-2914 |w (DE-627)129268852 |w (DE-600)80069-7 |w (DE-576)014459280 |x 0006-4971 |7 nnns |
| 773 | 1 | 8 | |g volume:127 |g year:2016 |g number:23 |g pages:2903-2914 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1182/blood-2015-10-675629 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26912466 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_290 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_2219 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4310 | ||
| 936 | r | v | |a XA 33000 |
| 951 | |a AR | ||
| 952 | |d 127 |j 2016 |e 23 |h 2903-2914 | ||